Human medicines European public assessment report (EPAR): Ontruzant, trastuzumab, Date of authorisation: 15/11/2017, Revision: 17, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 16 September 2026 - 15:08

Human medicines European public assessment report (EPAR): Ontruzant, trastuzumab, Date of authorisation: 15/11/2017, Revision: 17, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/ontruzant

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters